» Articles » PMID: 38404364

Incremental Dialysis: Two Complementary Views

Overview
Journal Clin Kidney J
Specialty Nephrology
Date 2024 Feb 26
PMID 38404364
Authors
Affiliations
Soon will be listed here.
Abstract

Franco Casino and Mariana Murea discuss today's knowledge about the 'incremental dialysis' concept. Franco Casino frames the problem by saying that, in the presence of substantial residual kidney function, kidney replacement therapy can begin with low doses and/or frequencies, to be gradually increased to compensate for any subsequent losses of residual kidney function, keeping the total clearance above the minimum levels of adequacy. He remarks that studies so far have documented that this approach is safe. He recognizes that adequate randomized controlled trials (RCTs) are necessary to confirm the safety and simplify and standardize the practical aspects of this approach. Mariana Murea objects that most of the evidence gathered so far primarily derives from retrospective and observational studies, which can be influenced by socioeconomic constraints. She argues for the need for RCTs to provide compelling empirical evidence on the efficacy of incremental dialysis. Nephrologists are still reluctant to adopt this approach for various reasons, including unfamiliarity with the method, lack of practical guidance and financial disincentives. Several countries have ongoing or planned RCTs comparing incremental dialysis with conventional dialysis. These trials can shift the haemodialysis paradigm if they validate the safety and effectiveness of this approach. The moderators believe that the results of ongoing trials must be carefully interpreted, and further validation may be needed across different patient populations or healthcare settings. The ultimate goal is to gather robust evidence that could lead to widespread adoption of incremental haemodialysis, optimizing treatment, reducing overtreatment, preserving resources and improving patients' quality of life.

Citing Articles

Twice Weekly versus Thrice Weekly Hemodialysis-A Pilot Cross-Over Equivalence Trial.

Lee S, Pham N, Montez-Rath M, Bolanos C, Bonde S, Meyer T Clin J Am Soc Nephrol. 2024; .

PMID: 38922689 PMC: 11390027. DOI: 10.2215/CJN.0000000000000507.


Ten tips from the Swiss Working Group on Sustainable Nephrology on how to go green in your dialysis unit.

Pruijm M, Rho E, Woywodt A, Segerer S Clin Kidney J. 2024; 17(6):sfae144.

PMID: 38887470 PMC: 11180981. DOI: 10.1093/ckj/sfae144.

References
1.
Fernandez Lucas M, Ruiz-Roso G, Merino J, Sanchez R, Bouarich H, Herrero J . Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial. Trials. 2020; 21(1):206. PMC: 7031943. DOI: 10.1186/s13063-020-4058-0. View

2.
Deira J, Suarez M, Lopez F, Garcia-Cabrera E, Gascon A, Torregrosa E . IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients. BMC Nephrol. 2019; 20(1):8. PMC: 6325813. DOI: 10.1186/s12882-018-1189-6. View

3.
Wanner C, Lopau K, Haberstroh H . The safety and feasibility of incremental dialysis must be proven before its widespread use. Kidney Int. 2022; 101(3):468-471. DOI: 10.1016/j.kint.2022.01.007. View

4.
Casino F, Basile C . A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant. 2018; 33(6):1046-1053. DOI: 10.1093/ndt/gfx343. View

5.
Vilar E, Kaja Kamal R, Fotheringham J, Busby A, Berdeprado J, Kislowska E . A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. Kidney Int. 2021; 101(3):615-625. DOI: 10.1016/j.kint.2021.07.025. View